LC
ELV icon

Lavaca Capital’s Elevance Health ELV Stock Holding History

Lavaca Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.3K Hold
100
– – 0.01% 198
2025
Q4 		$35.1K Hold
100
– – 0.01% 191
2025
Q3 		$32.3K Hold
100
– – 0.01% 185
2025
Q2 		$38.9K Hold
100
– – 0.01% 179
2025
Q1 		$43.5K Hold
100
– – 0.02% 163
2024
Q4 		$36.9K Buy
+100
New +$41.8K 0.01% 208
2019
Q2 		– Sell
-68
Closed -$20K – 170
2019
Q1 		$20K Hold
68
– – 0.02% 214
2018
Q4 		$18K Buy
+68
New +$18.7K 0.02% 195

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Lavaca Capital's ELV Position: Q1 2026 in Review

Lavaca Capital held its Elevance Health (ELV) position steady in Q1 2026 at 100 shares worth $29.3K. The position accounts for 0.01% of the portfolio, ranked #198.

Lavaca Capital first reported a position in ELV in Q4 2018 and has held it in 8 quarters since. The position peaked at $43.5K in Q1 2025. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Lavaca Capital held 100 shares of Elevance Health worth $29.3K as of Q1 2026.
  • Lavaca Capital left its Elevance Health share count unchanged in Q1 2026.
  • Elevance Health made up 0.01% of Lavaca Capital's portfolio in Q1 2026, its #198 holding.
  • Lavaca Capital first reported a position in Elevance Health in Q4 2018 and has held it in 8 quarters since.
  • Lavaca Capital's Elevance Health position peaked at $43.5K in Q1 2025.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Lavaca Capital's 13F filing for Q1 2026, filed 13 May 2026.